334 related articles for article (PubMed ID: 30808896)
1. Untargeted metabolomics by high resolution mass spectrometry coupled to normal and reversed phase liquid chromatography as a tool to study the in vitro biotransformation of new psychoactive substances.
Manier SK; Keller A; Schäper J; Meyer MR
Sci Rep; 2019 Feb; 9(1):2741. PubMed ID: 30808896
[TBL] [Abstract][Full Text] [Related]
2. Comparison of reversed-phase, hydrophilic interaction, and porous graphitic carbon chromatography columns for an untargeted toxicometabolomics study in pooled human liver microsomes, rat urine, and rat plasma.
Hemmer S; Manier SK; Wagmann L; Meyer MR
Metabolomics; 2024 Apr; 20(3):49. PubMed ID: 38689195
[TBL] [Abstract][Full Text] [Related]
3. Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts.
Manier SK; Wagmann L; Flockerzi V; Meyer MR
Arch Toxicol; 2020 Jun; 94(6):2047-2059. PubMed ID: 32313995
[TBL] [Abstract][Full Text] [Related]
4. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
Grafinger KE; Hädener M; König S; Weinmann W
Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
[TBL] [Abstract][Full Text] [Related]
5. LC-MS untargeted metabolomics assesses the delayed response of glufosinate treatment of transgenic glufosinate resistant (GR) buffalo grasses (Stenotaphrum secundatum L.).
Boonchaisri S; Rochfort S; Stevenson T; Dias DA
Metabolomics; 2021 Feb; 17(3):28. PubMed ID: 33609206
[TBL] [Abstract][Full Text] [Related]
6. Tailored liquid chromatography-mass spectrometry analysis improves the coverage of the intracellular metabolome of HepaRG cells.
Cuykx M; Negreira N; Beirnaert C; Van den Eede N; Rodrigues R; Vanhaecke T; Laukens K; Covaci A
J Chromatogr A; 2017 Mar; 1487():168-178. PubMed ID: 28153450
[TBL] [Abstract][Full Text] [Related]
7. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
[TBL] [Abstract][Full Text] [Related]
8. Comparison of peak-picking workflows for untargeted liquid chromatography/high-resolution mass spectrometry metabolomics data analysis.
Rafiei A; Sleno L
Rapid Commun Mass Spectrom; 2015 Jan; 29(1):119-27. PubMed ID: 25462372
[TBL] [Abstract][Full Text] [Related]
9. Application of liquid chromatography coupled to data-independent acquisition mass spectrometry for the metabolic profiling of N-ethyl heptedrone.
Mazzarino M; Camuto C; Comunità F; de la Torre X; Stacchini C; Botrè F
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122989. PubMed ID: 34678705
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
Michely JA; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
[TBL] [Abstract][Full Text] [Related]
12. Isotope Labeling-Assisted Evaluation of Hydrophilic and Hydrophobic Liquid Chromatograph-Mass Spectrometry for Metabolomics Profiling.
Xie B; Wang Y; Jones DR; Dey KK; Wang X; Li Y; Cho JH; Shaw TI; Tan H; Peng J
Anal Chem; 2018 Jul; 90(14):8538-8545. PubMed ID: 29883117
[TBL] [Abstract][Full Text] [Related]
13. Liquid Chromatography-High-Resolution Mass Spectrometry-Based In Vitro Toxicometabolomics of the Synthetic Cathinones 4-MPD and 4-MEAP in Pooled Human Liver Microsomes.
Manier SK; Schwermer F; Wagmann L; Eckstein N; Meyer MR
Metabolites; 2020 Dec; 11(1):. PubMed ID: 33374857
[TBL] [Abstract][Full Text] [Related]
14. Suspect and non-target screening workflows to investigate the in vitro and in vivo metabolism of the synthetic cannabinoid 5Cl-THJ-018.
Vervliet P; Mortelé O; Gys C; Degreef M; Lanckmans K; Maudens K; Covaci A; van Nuijs ALN; Lai FY
Drug Test Anal; 2019 Mar; 11(3):479-491. PubMed ID: 30242979
[TBL] [Abstract][Full Text] [Related]
15. In vitro phase I metabolism of three phenethylamines 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using microsomal and microbial models.
Grafinger KE; Stahl K; Wilke A; König S; Weinmann W
Drug Test Anal; 2018 Oct; 10(10):1607-1626. PubMed ID: 29971945
[TBL] [Abstract][Full Text] [Related]
16. Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry.
Boudah S; Olivier MF; Aros-Calt S; Oliveira L; Fenaille F; Tabet JC; Junot C
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():34-47. PubMed ID: 24815365
[TBL] [Abstract][Full Text] [Related]
17. Prediction of biotransformation products of the fungicide fluopyram by electrochemistry coupled online to liquid chromatography-mass spectrometry and comparison with in vitro microsomal assays.
Mekonnen TF; Panne U; Koch M
Anal Bioanal Chem; 2018 Apr; 410(10):2607-2617. PubMed ID: 29455286
[TBL] [Abstract][Full Text] [Related]
18. Capsaicin metabolites and GSH-associated detoxification and biotransformation pathways in human liver microsomes revealed by LC-HRMS/MS with data-mining tools.
Qin L; Wang Y; Gong Y; Chen J; Xu B; Tang L; Guo L; Xie J
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Dec; 1133():121843. PubMed ID: 31704446
[TBL] [Abstract][Full Text] [Related]
19. Pyrrolidinyl Synthetic Cathinones α-PHP and 4F-α-PVP Metabolite Profiling Using Human Hepatocyte Incubations.
Carlier J; Diao X; Giorgetti R; Busardò FP; Huestis MA
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379373
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MS(n) standard screening approaches.
Helfer AG; Turcant A; Boels D; Ferec S; Lelièvre B; Welter J; Meyer MR; Maurer HH
Drug Test Anal; 2015 May; 7(5):368-75. PubMed ID: 24953431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
